Bausch + Lomb and Modulight have entered into an exclusive agreement to develop a laser for use with Visudyne photodynamic therapy, according to a press release.
Visudyne (verteporfin for injection, Bausch + Lomb), an injectable photosensitizer drug for the treatment of choroidal neovascularization due to age-related macular degeneration, pathologic myopia or presumed ocular histoplasmosis, is activated through a photodynamic laser delivering a targeted approach that destroys abnormal choroidal blood vessels.
“PDT continues to be an important option for eye care professionals who treat
Uncategorized